ARHGDIB and cancer: Similar to the observation that KDM6A regulated ARHGDIB expression in a cancer-specific manner (Fig. S3e), among all four cell lines for different cancer types, the GSKJ4 treatment only inhibited ARHGDIB expression in HeLa and MKN-45 cells (Fig. S6f-i).